Clinical trial
Modulation of Opiate Reward by NK1 Antagonism: A Laboratory-Based Proof of Concept Study
NCT00726960 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Opiate Reward by NK1 Antagonism: A Laboratory-Based Proof of Concept Study
- Lead sponsor
- Karolinska University Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 31, 2008
- Completion date
- June 30, 2010
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.